Valeos Pharma A/S: Financial statements 2021
CVR: 39696614
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Valeos Pharma A/S (CVR 39696614) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -3,379,088 and a net result of DKK -6,408,155 compared with DKK -1,704,956 the year before. Equity in the 2021 report amounted to DKK 16,531,542. The solvency ratio was 33.1%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -3,379,088
- Profit/Loss
- DKK -6,408,155
- Equity
- DKK 16,531,542
- Total Assets
- DKK 49,944,908
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -3.4M | -6.4M | 16.5M | 7 |
| 2020 | - | -1.3M | -1.7M | -1.4M | 2 |
Official annual report
Find more companies like Valeos Pharma A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 22, 2021, Peter Frederik Andreasen has stepped down as director of Valeos Pharma A/S.
As of October 11, 2021, Peter Frederik Andreasen has joined the board of directors of Valeos Pharma A/S.
As of October 11, 2021, Michael Andreasen has left the board of directors of Valeos Pharma A/S.
As of October 6, 2021, Peter Frederik Andreasen is registered as director of Valeos Pharma A/S.
As of October 6, 2021, Birgitte Steen Frydland is registered as adm. dir. of Valeos Pharma A/S.
As of October 5, 2021, Peter Frederik Andreasen has stepped down as adm. dir. of Valeos Pharma A/S.
Valeos Pharma A/S has published its annual report for 2020. Gross profit came to DKK -1,276,838, and the net result was DKK -1,704,956.
As of April 15, 2021, Kristian Schrøder Hart-Hansen has joined the board of directors of Valeos Pharma A/S.
As of April 15, 2021, Glenn Steven Nielsen has joined the board of directors of Valeos Pharma A/S.
As of April 14, 2021, Kristian Schrøder Hart-Hansen has left the board of directors of Valeos Pharma A/S.
About Valeos Pharma A/S
Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The board consists of Glenn Steven Nielsen (chair), Kristian Schrøder Hart-Hansen, Michael Halborg-Bendtsen and Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.